ATOM-1 Trademark

Trademark Overview


On Friday, January 12, 2024, a trademark application was filed for ATOM-1 with the United States Patent and Trademark Office. The USPTO has given the ATOM-1 trademark a serial number of 98355762. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Saturday, February 8, 2025. This trademark is owned by Atomic AI, Inc.. The ATOM-1 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable computer software platforms for use in developing therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; providing online non-downloadable computer software platforms for use in automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; providing online non-downloadable computer software platforms for use in drug design and development featuring machine-learning algorit...
atom-1

General Information


Serial Number98355762
Word MarkATOM-1
Filing DateFriday, January 12, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateSaturday, February 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 17, 2024

Trademark Statements


Pseudo MarkATOM ONE
Goods and ServicesProviding online non-downloadable computer software platforms for use in developing therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; providing online non-downloadable computer software platforms for use in automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; providing online non-downloadable computer software platforms for use in drug design and development featuring machine-learning algorithms and lab automation tools; research and development of pharmaceuticals, namely, therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; research and development in the fields of biotechnology, DNA, RNA, molecules and proteins; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools; developing customized software in the field of drug design and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 11, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtomic AI, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAtomic AI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Friday, January 12, 2024NEW APPLICATION ENTERED
Monday, May 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 9, 2024ASSIGNED TO EXAMINER
Thursday, August 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 7, 2025SOU TEAS EXTENSION RECEIVED
Saturday, February 8, 2025SOU EXTENSION 1 FILED
Saturday, February 8, 2025SOU EXTENSION 1 GRANTED
Saturday, February 8, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED